Kyle W. H. Chan

DFO Management /Private Equity/ (DFO) is a private equity subsidiary of MSD Capital Management LLC founded in 1998 by Glenn Robert Fuhrman and John Cartwright Phelan. The firm is headquartered in New York.

FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA.

Sulfagenix, Inc. operates as a biotechnology company. It offers SG1002, a natural-occurring molecule and hydrogen sulfide for, which deficits have been shown to exist in various serious diseases, including cardiovascular disease, type II diabetes, cancer, hypertension, Alzheimer’s disease, asthma, and wound healing. The company was founded by David Lefer and Gabriel Gojon, Sr. in 2011 and is headquartered in Chesterland, OH.

Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH.

University of Akron provides public research education. Its programs include under graduate studies, graduate studies, international studies, law, and continuing education. The company was founded in 1870 and is headquartered in Akron, OH.

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.

Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA.

Alteris Therapeutics, Inc. develops therapeutic cancer vaccine products. It engages in engages in the discovery and development of therapeutics and vaccines based on alternative gene splice forms for the treatment of cancer. The company was founded by Donald M. O’Rourke and Albert Wong in 2002 and is headquartered in Philadelphia, PA.

The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY.

Young Presidents' Organization, Inc. is a global leadership community of over 30,000 chief executives from 142 countries. The non-profit company is based in Irving, TX and has a global presence of subsidiaries in several regions. The company's mission is to help its members become better leaders and better people. The company was founded in 1950 by Ray Hickok, Khalid Mohamed Jassem Kanoo. Thayer Smith has been the CEO of the company since 2007.

BioEnterprise Corp. provides access to capital through both its relationships with venture capital and investment banking firms. It initiates for start up funding, and networking information, recruitment, and emerging support firms, including medical devices companies. The company was founded in 2002 and is headquartered in Cleveland, OH.

Part of Patrys Ltd., Acceptys, Inc. develops natural antibody technologies for infectious disease applications. The company is based in Sparta, NJ. Acceptys was acquired by Patrys Ltd. on December 03, 2008 for $2 million.

Physician Investment Group LLC provides investment services. The private company is based in Dayton, OH. The company was founded by Amol Soin.

Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland.

Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA.

Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA.

Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA.

NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH.

American Society of Interventional Pain Physicians, Inc. is an association that provides ambulatory and pain management services. The private company is based in Paducah.

Merand Pharmaceuticals, Inc. engages in the provision of therapeutic products. It is developing a novel microRNA therapeutic (MicroRNA93 or miR-93) to treat patients suffering from Peripheral Arterial Disease (PAD). The company was founded in 2018 and is headquartered in Charlottesville, VA.

TEN63 Therapeutics provides drug development services. The American company was founded by Nancy Miller-Rich, Marcel Frenkel, Mark Hallen, Bruce Donald. Marcel Frenkel has been the CEO since incorporation.

Soin Neuroscience, Inc. is a biotech company that specializes in non-opioid based pain management therapies. SNI is based in Dayton, OH and has recently started a medical device division, with several neuromodulation technologies in development. SNI is also working on machine learning and AI-based technologies to help augment physician decision making to make precision medicine possible. However, their sacral nerve stimulation device and spinal cord stimulation device are not approved for use in humans and are currently in early testing phases. The private company was founded by Amol Soin, MD, who has been the CEO since incorporation.

Part of JanOne, Inc., Soin Therapeutics LLC is a biotechnology company based in Dayton, OH. The company has developed multiple different drugs to treat several chronic conditions, with its lead product being a novel proprietary formulation of low dose naltrexone to treat complex regional pain syndrome (CRPS). Soin Therapeutics has received an orphan drug designation from the FDA for their lead product and is planning to commence a large national late-stage efficacy trial in 2022 of their lead product in CRPS patients. The company was founded by Amol Soin, who has been the CEO since incorporation. Soin Therapeutics was acquired by JanOne, Inc. on December 28, 2022 for $30 million.